论文部分内容阅读
目的:比较喜炎平注射液与利巴韦林注射液用于治疗登革热病患者的临床疗效。方法:选取2013年6月—2015年12月诊治的登革热病患者80例,根据不同的用药治疗方法将其分为观察组(n=41例)和对照组(n=39例);观察组患者均给予喜炎平注射液治疗,对照组患者均给予利巴韦林治疗,比较两组患者治疗后的总有效率和临床各指标的复常时间。结果:观察组患者治疗后的白细胞计数和血小板计数及异型淋巴细胞计数的复常时间均显著低于对照组各指标(t=3.121,2.513,3.618,P<0.05);观察组患者治疗后的痊愈率为75.61%高于对照组为35.90%(P<0.05)以及总有效率为92.68%显著高于对照组为75.61%(P<0.05)。结论:喜炎平注射液用于治疗登革热病患者的临床疗效较为确切,缩短了临床各指标复常时间。
Objective: To compare the clinical efficacy of Xiyanping injection and ribavirin injection in the treatment of dengue fever. Methods: Eighty dengue patients diagnosed and treated from June 2013 to December 2015 were divided into the observation group (n = 41) and the control group (n = 39) according to the different treatment methods. The observation group Patients were treated with Xiyanping injection, the control group were given ribavirin treatment, the two groups were compared after treatment, the total effective rate and clinical indicators of the time of rehospitalization. Results: The white blood cell count, platelet count and atypical lymphocyte count in observation group were significantly lower than those in control group after treatment (t = 3.121, 2.513, 3.618, P <0.05). After treatment, The cure rate was 75.61% higher than 35.90% (P <0.05) of the control group and the total effective rate was 92.68%, which was significantly higher than that of the control group (75.61%, P <0.05). Conclusion: Xiyanping injection for the treatment of dengue fever in patients with more precise clinical efficacy, shorten the clinical indicators of time of rehospitalization.